This inventor holds 4 USPTO granted patents. Top assignees: National Tsing Hua University, Industrial Technology Research Institute. Active years: 2013-2018.
Company Filing History:
3 out of 1,308 
1 out of 9,303 
Years Active: 2013-2018
Title: Hsi-Tsung Cheng: Innovator in Antimicrobial Peptides
Introduction
Hsi-Tsung Cheng is a prominent inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of antimicrobial peptides, holding a total of 4 patents. His work focuses on enhancing the resistance of these peptides to salt and proteases, which is crucial for their effectiveness in various applications.
Latest Patents
Cheng's latest patents include innovative methods for improving the properties of antimicrobial peptides. One of his notable inventions is a method for creating an antimicrobial peptide that features an amino terminal and/or carboxyl terminal linked with at least one artificial bulky amino acid. This design increases both salt resistance and protease resistance while maintaining low hemolytic activity. Another significant patent involves a high salt-resistance antibacterial peptide, achieved by modifying the width and length of the side chains of amino acids in the peptide. This advancement allows for enhanced salt resistance, making the antibacterial peptide more effective in challenging environments.
Career Highlights
Throughout his career, Hsi-Tsung Cheng has worked with esteemed institutions such as National Tsing Hua University and the Industrial Technology Research Institute. His research has contributed to the advancement of antimicrobial technologies, which are vital in combating bacterial infections.
Collaborations
Cheng has collaborated with notable colleagues, including Hui-Yuan Yu and Jya-Wei Cheng. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Hsi-Tsung Cheng's work in the field of antimicrobial peptides showcases his dedication to innovation and research. His patents reflect a commitment to enhancing the effectiveness of antimicrobial agents, which is essential for public health and safety.